Phase 3
Completed N=32
Spasmodic Dysphonia Pain
Spasmodic Dysphonia
Source: ClinicalTrials.gov NCT04648891 ↗
Enrolled (actual)
32
Serious AEs
0.0%
Results posted
May 2024
Primary outcomePrimary: Pain Experienced — 2; 2; 2 score on a scale
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
This study aims to identify adjuvant methods to improve patient comfort during in-office laryngology procedures.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Experienced |
2; 2; 2 | — |
| SECONDARY Subject Preference |
6; 12; 14 | — |
Eligibility Criteria
Inclusion Criteria
- Spasmodic dysphonia with or without tremor
- Receiving botox as treatment via a transcricothyroid approach
Exclusion Criteria
- Allergy to lidocaine
Data sourced from ClinicalTrials.gov (NCT04648891). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.